| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $346K | -44.4% | -46.4% |
| Cost of Revenue | $278K | -40.4% | -39.0% |
| Gross Profit | $69K | -56.3% | -64.1% |
| R&D Expense | $457K | -18.7% | -48.1% |
| SG&A Expense | $3.5M | +118.6% | +373.7% |
| Operating Income | -$3.9M | -93.7% | -172.0% |
| Interest Expense | $17K | — | — |
| Pre-tax Income | -$3.9M | -93.6% | -184.2% |
| Net Income | -$3.9M | -93.6% | -184.2% |
| EPS (Basic) | -$0.32 | +84.9% | -166.7% |
| EPS (Diluted) | -$0.32 | +84.9% | -166.7% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.3M | -24.1% | -6.8% |
| Accounts Receivable | $148K | -8.2% | +34.6% |
| Inventory | $136K | -1.5% | -19.2% |
| Current Assets | $5.8M | -22.7% | -6.1% |
| Total Assets | $8.4M | -17.3% | -32.9% |
| Current Liabilities | $773K | -50.9% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.4M | — | — |
| Capital Expenditures | $5K | — | — |
| Investing Cash Flow | -$5K | — | — |
| Financing Cash Flow | $5.4M | — | — |
| Free Cash Flow | -$4.4M | — | — |
| -38.1% |
| Total Liabilities | $870K | -48.3% | -33.6% |
| Stockholders' Equity | $7.5M | -11.1% | -32.8% |